UBS on $45bn in dry powder

Secondaries buyers are casting a wider net to fish for credit, intellectual property, healthcare royalties, and other sorts of illiquid assets, says Rodney Reid, head of UBS' secondaries activity for EMENA.

To view this content you must sign in:

Not yet registered? Join today to access Secondaries Investor’s industry insights and updates.